PharmaResources (Shanghai) Co. Ltd. A (301230) — Net Asset Momentum
PharmaResources (Shanghai) Co. Ltd. A (301230) recorded a net asset momentum of -2.8% as of December 2025, with net assets of CN¥1.00 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check PharmaResources (Shanghai) Co. Ltd. A (301230) tangible net worth to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
PharmaResources (Shanghai) Co. Ltd. A Net Asset Momentum (2020–2025)
This chart tracks PharmaResources (Shanghai) Co. Ltd. A's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -2.8%, with net assets of CN¥1.00 Billion CNY as of December 2025. Read PharmaResources (Shanghai) Co. Ltd. A balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
The table below shows the complete annual net asset history for PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PharmaResources (Shanghai) Co. Ltd. A (301230) market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.00 Billion | CN¥1.31 Billion | CN¥309.87 Million | ▼ -2.8% |
| 2024 | CN¥1.03 Billion | CN¥1.32 Billion | CN¥283.73 Million | ▼ -7.6% |
| 2023 | CN¥1.12 Billion | CN¥1.49 Billion | CN¥369.62 Million | ▲ +0.4% |
| 2022 | CN¥1.11 Billion | CN¥1.30 Billion | CN¥188.38 Million | ▲ +219.4% |
| 2021 | CN¥348.44 Million | CN¥557.81 Million | CN¥209.37 Million | ▲ +32.4% |
| 2020 | CN¥263.18 Million | CN¥373.99 Million | CN¥110.81 Million | — |